NASDAQ
CEN Biotech, Inc. (CENBF) has a free cash flow growth of 454.04% as of Friday, May 29, 2026. This represents a 2424.19% increase compared to its 12-month average of -19.54%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.